Richard M. Ferrari
Founder & Executive ChairmanMr. Richard M. Ferrari, also known as Rich, MBA, Vice Chairman of Advanced Bifurcation Systems Inc. He was Director of Anaconda Biomed SL since April 2023 until 2025 and was its Chairperson from April 2023 to January 2025. He has co-founded, led and advised scores of medical device and biotechnology companies. He serves as Chairman and Board Member of multiple medical device and biotech companies. He serves as Chairman at Medlumics S. L. since February 2021. He has experience in the healthcare industry, with a demonstrated history of working in the venture capital and private equity industry. He serves as the Director at Evren Technologies, Inc. He serves as Director at SIMARATO SAS (alternate name: BIOMODEX) since April 2021. He has been Director of PuraCath Medical, Inc. He has been Executive Director of HeartBeam, Inc. since June 2021 having served as a Board Member since 2019. He serves as the Executive Chairman of HeartBeam, Inc. since June 2021. He served as Chairman and Chief Executive Officer at PQ Bypass, Inc. since 2018. He serves as a Business Development Advisor and Founder at Denovo. He is a Co-Founder of De Novo Ventures and has been its Managing Director since 2000. He serves as the Chairman of MedLumics. Mr. Ferrari has wealth of experience in medical device innovation and commercialization. He has been Executive Chairman of SentreHEART, Inc. since May 25, 2016. He serves as a Business Development Advisor at Saratoga Ventures, L. P. He founded Saratoga Ventures, L.P in 1997. Mr. Ferrari served as an Acting Chairman and Interim Chief Executive Officer at Pacira CryoTech, Inc. Mr. Ferrari served as an Advisor of FitView Inc. He serves as the Chief Executive Officer of several medical technology companies. He served as an Advisor at Cytograft Tissue Engineering, Inc. From January 1990 to June 1995, he served as the Chief Executive Officer at Cardiovascular Imaging Systems. Prior to this from April 1990 to January 1991, he served as the President and Acting Chief Executive Officer at Medstone International. Previously, he also co-founded The Medical Technology Group. From January 1986 to April 1990, he served as an Executive Vice President and General Manager at ADAC Laboratories, where he was responsible for the nuclear medicine, digital cardiology and information management and radiation therapy business units. He was also the Co-Founder at Integrated Vascular Systems. Prior to that, from October 1995 to May 1999 he was a Co-Founder and Chief Executive Officer of CardioThoracic Systems, Inc. from June 1995 to March 2000 and President from August 1995 to 2000. In 2002, he served as the Chief Executive Officer of Paracor Medical, Inc. He is the Founder of Tenon Medical, Inc and serves as its Executive Chairman and has also been its Director since 2012. He is the Vice-Chairman of ABS Interventional. He serves as the Chairman at Converge Medical. He served as the Chairman of Pacira CryoTech, Inc. (formerly known as myoscience, Inc.) until January 6, 2012. He served as the Chairman of CryoVascular Systems, Inc He served as the Chairman of ORATEC Interventions, Inc. since January 1997 and its Director since May 1996. He serves as a Director and Advisor at several start-up companies in the medical device industry. He serves as Director of EndoShape, Inc. He serves as Director of Roxwood Medical, Inc. and Advanced Bifurcation Systems Inc. He serves as an Independent Director of Pulmonx Corporation since December 2007. He serves as a Director for Fixes-4-Kids, Inc. Bacchus Vascular, MyoScience, Ovalis, Inc. Spinal Modulation, Inc. Benvenue Medical Inc. CardioMind, Simpirica, Pacira CryoTech, Inc. Paracor Medical, Inc. Spinal Kinetics LLC, CAVU Medical, Inc. ProMed, Inc. Reduction Technologies, Inc. Spiracur Inc. and Simpirica Spine, Inc. He was instrumental in developing the clinical and product strategies and hiring the executive team. He has been a Director of SentreHEART, Inc. since August 24, 2015. He served as s Director of Calcitec, Inc. FitView Inc. Carepanion, Cytograft Tissue Engineering Inc. and SynergEyes, Inc. He currently is a board member of Retriever Medical Inc.; a board member of RMx Medical; a board member of Hawthorne Effect, Inc.; Executive Chairman of Sentreheart acquired by Atricure and a board member of Hands of Hope. Previously he served as the Director at Foxhollow Technologies Inc. from April 2001 to June 2005 and FemRx Inc. since October 1995. He served as Director at CardioThoracic Systems, Inc. He was a Board Member at TriVascular. He serves as a Faculty Member of the Stanford Biodesign Emerging Entrepreneurs Forum and also sits on the Stanford Coulter Foundation Board for evaluation and subsequent grants for novel translational medical innovation ideas. Since 2000, Mr. Ferrari has been is a Managing Director of Denovo Ventures. He served as a Director of Corazon Technologies Inc. Sinus Rhythm Technologies Inc. NorthPoint Domain and Ben Venue Laboratories, Inc. He received the Mallinckrodt Award for Excellence in Medicine and is a past finalist for the Entrepreneur of the Year Award. Mr. Ferrari holds an M.B.A. from the University of South Florida and a Bachelor's degree in Education from Ashland University.
Positions
- Company NameTenon Medical, Inc.Stock CodeTNONPositionFounder & Executive ChairmanRelated Securities
- Company NameHeartBeam, Inc.Stock CodeBEATPositionExecutive ChairmanColleagues
- RMRichard M. FerrariExecutive Chairman
- BVBranislav VajdicFounder, President & Director
- TCTimothy CruickshankChief Financial Officer
- KPKenneth PersenChief System Development Officer
- PJPeter J. FitzgeraldMember of Scientific Advisory Board & Chief Medical Advisor
- MOMarga Ortigas-WedekindIndependent Director
- GAGeorge A. De UriosteIndependent Director
- Company NamePulmonx CorporationStock CodeLUNGPositionIndependent DirectorColleagues
- GEGlendon E. FrenchCEO, President & Director
- DGDana George MeadIndependent Chairperson of the Board
- DSDerrick SungCFO & COO
- DADavid A. LehmanGeneral Counsel & Secretary
- SRSrikanth RadhakrishnanChief Science & Technology Officer
- MMMarcee M. MaroneyVice President of Marketing
- RMRichard M. FerrariIndependent Director
- DPDaniel P. FlorinIndependent Director
- GGGeorgia Garinois-MelenikiotouIndependent Director
